The association between TP53 rs1042522 polymorphism and cervical cancer was first reported in a study published in 1998, which showed that women who are homozygous for arginine at codon 72 of TP53 gene were seven times more likely to develop cervical cancer than heterozygous women (6). The gene discussed is TP53; the disease is cervical cancer.